Imaging blood flow in leg muscles of people with peripheral artery disease
Tests scans of leg muscle blood flow in people with peripheral artery disease.
Key facts
- Who runs it
- Nationwide Children's Hospital
- Where
- Columbus, United StatesSee the site
- Trial code
- Registry title
- Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
- Status
- Recruiting
- People taking part
- 192 people, planned
- Started
- 17 Feb 2017
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- SPECT/CT perfusion imaging
- PET/CT perfusion imaging
- Record updated
- 23 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral artery disease (narrowed leg arteries) who are already scheduled for a procedure to restore blood flow in the leg. It is also looking for healthy adults without this disease as a comparison group.
- Age
- 18 years and older.
- Sex
- All sexes can join.
- Disease stage
- Patients: significant blockage in one or more leg arteries. Healthy volunteers: no sign or past diagnosis of peripheral artery disease.
- Earlier treatment
- Patients must already be scheduled for a procedure to restore blood flow in the leg (revascularization).
- Biomarker or test result
- Patients: blockage shown by an earlier ABI, TBI, CT angiography, ultrasound, or MR imaging.
Main reasons for not taking part
- Not able to give informed consent or attend follow-up
- Pregnant or breastfeeding
- Under 18 years of age
- Patients: no history of peripheral artery disease
- Healthy volunteers: any history of peripheral artery disease
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- At least 18 years of age
- Evidence of significant obstructive disease for one or multiple lower extremity arteries, as identified by prior ABI, TBI, CT angiography, ultrasound, or MR imaging
- At least 18 years of age
- No evidence or prior diagnosis of peripheral artery disease based on chart review and standard vascular screening
Who cannot take part
- No history of peripheral artery disease
- History of peripheral artery disease
- Under the age of 18
- Under the age of 18
- Unable to give informed consent or follow-up
- Pregnant or nursing
- Unable to give informed consent of follow-up
- Pregnant or nursing
Where in United States
- Nationwide Children's HospitalColumbus, United StatesContact: Mitchel R Stacy, Ph.D.Taking people
About the trial
What the trial wants to find out
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower extremities will provide a sensitive non-invasive imaging tool for quantifying regional abnormalities in skeletal muscle perfusion and evaluating responses to medical treatment.
The 2 groups in the trial
- SPECT/CT perfusion imagingTreatment being tested
Patients with peripheral artery disease will have already been scheduled for clinically indicated revascularization procedures of the lower extremity and undergo SPECT/CT imaging as part of the research protocol.
Treatment: SPECT/CT perfusion imaging and PET/CT perfusion imaging
- PET/CT perfusion imagingTreatment being tested
Patients with peripheral artery disease will have already been scheduled for clinically indicated revascularization procedures of the lower extremity and undergo PET/CT imaging as part of the research protocol.
Treatment: SPECT/CT perfusion imaging and PET/CT perfusion imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Radiotracer Imaging of Skeletal Muscle Perfusion in Patients With Peripheral Artery Disease
- Plain-language title
- Imaging blood flow in leg muscles of people with peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Quantification of Skeletal Muscle Perfusion in Peripheral Artery Disease Using 18F-Sodium Fluoride Positron Emission Tomography Imaging.Journal of the American Heart Association, 2024
- Prognostic Value of Radiotracer-Based Perfusion Imaging in Critical Limb Ischemia Patients Undergoing Lower Extremity Revascularization.JACC. Cardiovascular imaging, 2021
- Record updated
- 23 October 2026